Friday, June 22, 2018 12:57:43 AM
In other words, the exact opposite of AMFE’s situation.
When this audit finally vindicates the longs here, we’ll see what’s what. I don’t expect anything different than what we already know; that the company’s in great shape and expanding steadily with cash flow aplenty that is wisely being used to fund further growth.
Like O’Leary says: “Cash flooooow”.
Keep comin’, bears. Give it all ya got.
$AMFE, b*tches!
Only invest that which you can afford to lose.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM